BackCeryvyn Therapeutics Overview

Ceryvyn Therapeutics Receivables

Track Ceryvyn Therapeutics's receivables ($420K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$421066.00
↓ 94.73% YoYΔ $-7.56M vs prior year quarter

Peer trimmed avg / median

Loading

Ceryvyn Therapeutics Receivables History

Loading

Ceryvyn Therapeutics vs. peers: Receivables Comparison

Loading

Ceryvyn Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Ceryvyn Therapeutics (OPT.AX) FAQ

Ceryvyn Therapeutics (OPT.AX) currently reports a receivables of $420K as of December 2025. That compares with $8M in the prior-year period — down 94.7% year over year. Use the charts on this page to explore Ceryvyn Therapeutics's receivables history and peer comparisons.

Ceryvyn Therapeutics's receivables decreased from $8M to $420K — a 94.7% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ceryvyn Therapeutics reported $420K in receivables as of December 2025. That compares with $8M in the prior-year period — down 94.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $420K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ceryvyn Therapeutics, and consider following OPT.AX for alerts when major investors trade the stock.

Ceryvyn Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $420K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPT.AX with unrelated industries.